Drugs with a glucagon-like peptide-1 (GLP-1) classification such as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro, help in the regulation of digestion, appetite, and sugar which aid in weight loss
They are usually just disgusting, not painful, but sometimes they can get unpleasant like a thorn in the lions paw
Now that weve worked through the FDAs confusing regulations, heres what you can expect when you choose our team to guide you through your weight loss journey
Wegovy, the third medication, is specifically intended for weight management in individuals who are either overweight or obese, regardless of whether they have diabetes
Building a brand is not a weekend project
Writing a diabetes code when the patient doesn't have diabetes is fraud